Pepgen

About:

PepGen is empowering nucleic acid therapeutics to go the distance.

Website: https://pepgen.com/

Twitter/X: PepGenTx

Top Investors: Innovate UK, Deerfield, Oxford Science Enterprises, Perceptive Advisors, RA Capital Management

Description:

PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and they are advancing novel conjugate therapeutics to the clinic.

Total Funding Amount:

$240M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2018-01-01

Contact Email:

info(AT)pepgen.com

Founders:

Caroline Godfrey, Matthew Wood, Michael Gait

Number of Employees:

101-250

Last Funding Date:

2024-02-07

IPO Status:

Public

Industries:

© 2025 bioDAO.ai